Literature DB >> 11162550

Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells.

H Hemmi1, H Okuyama, T Yamane, S Nishikawa, T Nakano, H Yamazaki, T Kunisada, S Hayashi.   

Abstract

Osteoclasts are hematopoietic cells essential for bone resorption. To understand the process of osteoclastogenesis, we have developed a culture system that employs a stromal cell line, in which differentiation of osteoclasts from single embryonic stem (ES) cells occurs. This culture, which did not require any cell passaging or other manipulations, enabled us to investigate the temporal and spatial localization of the osteoclast lineage in the colonies formed from ES cells. Cells expressing tartrate-resistant acid phosphatase, a specific marker of the osteoclast lineage, were first detected on day 8, and subsequently became localized at the periphery of colonies and matured into multinucleated cells to resorb bone. Addition of macrophage colony-stimulating factor and osteoprotegerin-ligand, which are produced by stromal cells, promoted osteoclastogenesis in whole colonies, indicating that the location and maintenance of mature osteoclasts as well as the growth and differentiation of osteoclast precursors are regulated by these two factors. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162550     DOI: 10.1006/bbrc.2000.4153

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Designer blood: creating hematopoietic lineages from embryonic stem cells.

Authors:  Abby L Olsen; David L Stachura; Mitchell J Weiss
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

2.  Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.

Authors:  Keizo Nishikawa; Yoriko Iwamoto; Masaru Ishii
Journal:  J Bone Miner Metab       Date:  2013-12-24       Impact factor: 2.626

3.  The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone Disorders.

Authors:  I-Ping Chen
Journal:  J Clin Med       Date:  2014-12-17       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.